These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22759799)

  • 1. Risk stratification in patients with advanced heart failure requiring biventricular assist device support as a bridge to cardiac transplantation.
    Cheng RK; Deng MC; Tseng CH; Shemin RJ; Kubak BM; MacLellan WR
    J Heart Lung Transplant; 2012 Aug; 31(8):831-8. PubMed ID: 22759799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure.
    Levin AP; Jaramillo N; Garan AR; Takeda K; Takayama H; Yuzefpolskaya M; Mancini DM; Naka Y; Colombo PC; Topkara VK
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):530-5.e2. PubMed ID: 26651960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
    Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study.
    Holman WL; Kormos RL; Naftel DC; Miller MA; Pagani FD; Blume E; Cleeton T; Koenig SC; Edwards L; Kirklin JK
    J Heart Lung Transplant; 2009 Jan; 28(1):44-50. PubMed ID: 19134530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of pre-operative interleukin-6 levels with Interagency Registry for Mechanically Assisted Circulatory Support profiles and intensive care unit stay in left ventricular assist device patients.
    Caruso R; Verde A; Cabiati M; Milazzo F; Boroni C; Del Ry S; Parolini M; Vittori C; Paino R; Martinelli L; Giannessi D; Frigerio M; Parodi O
    J Heart Lung Transplant; 2012 Jun; 31(6):625-33. PubMed ID: 22386451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS)-defined morbidity and mortality associated with pediatric ventricular assist device support at a single US center: the Stanford experience.
    Stein ML; Robbins R; Sabati AA; Reinhartz O; Chin C; Liu E; Bernstein D; Roth S; Wright G; Reitz B; Rosenthal D
    Circ Heart Fail; 2010 Nov; 3(6):682-8. PubMed ID: 20807863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial clinical experience with the HeartWare left ventricular assist system: a single-center report.
    Dell'Aquila AM; Schneider SR; Schlarb D; Redwan B; Sindermann JR; Ellger B; Stypmann J; Tjan TD; Scheld HH; Hoffmeier A
    Ann Thorac Surg; 2013 Jan; 95(1):170-7. PubMed ID: 23141906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumatic pulsatile ventricular assist device as a bridge to heart transplantation in pediatric patients.
    Amodeo A; Brancaccio G; Michielon G; Filippelli S; Ricci Z; Morelli S; Gagliardi MG; Iacobelli R; Pongiglione G; Di Donato RM
    Artif Organs; 2010 Nov; 34(11):1017-22. PubMed ID: 21092045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
    J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New circulatory support system: heartware.
    Ozbaran M; Yagdi T; Engin C; Nalbantgil S; Ayik F; Oguz E; Engin Y; Özturk P
    Transplant Proc; 2012; 44(6):1726-8. PubMed ID: 22841255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biventricular cannulation is superior regarding hemodynamics and organ recovery in patients on biventricular assist device support.
    Schlensak C; Schibilsky D; Siepe M; Brehm K; Klemm R; von Wattenwyl R; Berchthold-Herz M; Benk C; Beyersdorf F
    J Heart Lung Transplant; 2011 Sep; 30(9):1011-7. PubMed ID: 21489816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure.
    Lund LH; Aaronson KD; Mancini DM
    Am J Cardiol; 2005 Mar; 95(6):734-41. PubMed ID: 15757599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
    Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.